March 17, 2020 / 10:24 PM / 22 days ago

BRIEF-Ideaya Biosciences Says Co Entered Into Clinical Trial Collaboration And Supply Agreement With Pfizer

March 17 (Reuters) - IDEAYA Biosciences Inc:

* IDEAYA BIOSCIENCES - EFFECTIVE AS OF MARCH 11, ENTERED INTO CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT WITH PFIZER INC.

* IDEAYA - AS PER COLLABORATION & SUPPLY AGREEMENT, CO & PFIZER WILL COLLABORATE ON PORTION OF CO’S PHASE 1/2 STUDY IN METASTATIC UVEAL MELANOMA

* IDEAYA - CO & PFIZER WILL COLLABORATE ON PORTION OF CO'S PHASE 1/2 STUDY FOR OTHER SOLID TUMORS HARBORING ACTIVATING GNAQ OR GNA11 HOTSPOT MUTATIONS Source text: (bit.ly/2WmLLu7) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below